Posted On: April 02, 2019
The University of Sydney is Australia’s first university, founded in 1850 on the principle of providing higher education for all.
It was one of the first universities in the world to admit students on academic merit, and women on the same basis as men. Today the University is ranked in the world’s top 50 universities, reflecting its outstanding reputation for leadership in research and education.
Meet a scientist we've funded at The University of Sydney
Dr Elizabeth Hovey
Dr Elizabeth Hovey is a Senior Staff Specialist in Medical Oncology at Prince of Wales Hospital, Conjoint Senior Lecturer at UNSW, and Honorary Associate of the University of Sydney.
After completing advanced training at Royal Prince Alfred Hospital, she completed further post-graduate training at Columbia-Presbyterian Medical Centre, New York, NY, USA (1998-2001) during which time she was the recipient of a full scholarship to complete a Master of Biostatistics in Patient-Oriented Research at Columbia University School of Public Health (1999-2001). Prior to her 2007 appointment at Prince of Wales Hospital, she was a medical oncologist at Liverpool Hospital.
Dr Hovey is currently Secretary/Operations Executive Member of the Cooperative Trials Group for Neuro-oncology (COGNO), and was previously Chair of COGNO’s Scientific Advisory Committee. She was a previous Chair of the COSA (Clinical Oncological Society of Australia) Neuro-oncology Group after two elected terms (2006-2010); Co-Founder and current Co-Chair of the NSW Neuro-oncology Group at the NSW Cancer Institute. She was the Project Officer for the development of “Australian Clinical Practice Guidelines for the Management Adult Gliomas: Astrocytomas and Oligodendrogliomas” on behalf of Australian Cancer Network, and was on the Working Party and Co-Editor of the subsequent matching Consumer Guidelines.
Read more: Personalised targeted therapy for adolescent and young adult medulloblastoma patients